Related Experiment Video
Updated: Sep 7, 2025
04:56
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
840
The problem with coagulopathy …
1Department of Haematology, Manchester University Hospitals, Manchester, UK.
Journal of Thrombosis and Haemostasis : JTH
|June 23, 2022
Summary
Coagulopathy, a condition linked to hemostasis and thrombosis, can cause either bleeding or clot formation. Clarifying its definition is crucial for specialists to avoid confusion in clinical practice.
Area of Science:
- Hematology
- Thrombosis research
- Hemostasis studies
Background:
- Coagulopathy is closely associated with hemostasis and thrombosis.
- It can manifest as either bleeding or abnormal clot formation.
- The term "coagulopathy" can lead to clinical confusion due to its dual implications.
Discussion:
- This ambiguity necessitates a clear definition and precise application of the term coagulopathy.
- Hemostasis and thrombosis specialists must address this terminological challenge.
- Ensuring correct usage will improve diagnostic accuracy and patient care.
Key Insights:
- Coagulopathy presents a diagnostic challenge due to its association with both bleeding and thrombosis.
- The term "coagulopathy" requires precise definition to prevent clinical misunderstanding.
- Specialists must standardize the usage of coagulopathy in scientific and clinical contexts.
Outlook:
- Future research should focus on refining the definition of coagulopathy.
- Clearer terminology will enhance understanding and management of bleeding and thrombotic disorders.
- Establishing standardized nomenclature is essential for advancing hemostasis and thrombosis research.
More Related Videos
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
628
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
13.9K
Related Concept Videos
01:06Coagulation
370
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
370
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
884
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
884
02:45Blood Transfusion and Agglutination
11.1K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.1K
01:05Introduction to Hemostasis
8.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.8K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
9.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.1K